Search

everythinglearnresearchcommunity

for

Search:↓

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

A woman with lupus and systemic sclerosis developed severe acne that didn't improve with treatment and died from pneumonia and septic shock.

Ayurvedic treatments can improve symptoms and quality of life for systemic sclerosis patients.

A high fat lard diet may protect against skin fibrosis and affect hair growth.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

Most patients with Tuberous sclerosis had neurological or skin issues, and over half had psychiatric problems.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Hair thinning is a common but generally mild and reversible side effect of teriflunomide in multiple sclerosis patients.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Giving dihydrotachysterol to mother rats caused skin hardening and bone issues in their babies through milk.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Post-void residual volume does not predict worsening urological symptoms in multiple sclerosis patients.

EPDS and MS might share an immune-related cause.

Warming hands improves blood flow in people with systemic sclerosis.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.